| 22456526 | Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). | Lung Cancer | 2012 Jul | Liu YZ | doi: 10.1016/j.lungcan.2012.03.001 |
| 24166506 | Depletion of minichromosome maintenance protein 7 inhibits glioblastoma multiforme tumor growth in vivo. | Oncogene | 2014 Sep 25 | Erkan EP | doi: 10.1038/onc.2013.423 |
| 17094475 | Immunohistochemical evaluation of minichromosome maintenance protein 7 in astrocytoma grading. | Anticancer Res | 2006 Sep-Oct | Facoetti A | - |
| 28498460 | MCM7 amplification and overexpression promote cell proliferation, colony formation and migration in esophageal squamous cell carcinoma by activating the AKT1/mTOR signaling pathway. | Oncol Rep | 2017 Jun | Qiu YT | doi: 10.3892/or.2017.5614 |
| 18636144 | Minichromosome maintenance protein 7 in colorectal cancer: implication of prognostic significance. | Int J Oncol | 2008 Aug | Nishihara K | - |
| 23764002 | Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers. | Cancer Cell | 2013 Jun 10 | Huang TH | doi: 10.1016/j.ccr.2013.04.027. |
| 14678972 | Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. | Cancer Res | 2003 Dec 1 | Brake T | - |
| 24324072 | Comparison of minichromosome maintenance proteins (MCM-3, MCM-7) and metallothioneins (MT-I/II, MT-III) expression in relation to clinicopathological data in ovarian cancer. | Anticancer Res | 2013 Dec | Kobierzycki C | - |
| 21619671 | Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer. | Mol Cancer | 2011 May 28 | Toyokawa G | doi: 10.1186/1476-4598-10-65. |
| 21076460 | Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary. | Mod Pathol | 2011 Feb | Ota T | doi: 10.1038/modpathol.2010.202 |
| 23201130 | Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer. | Am J Pathol | 2013 Feb | Fristrup N | doi: 10.1016/j.ajpath.2012.10.017 |
| 26966728 | Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines. | Investig Clin Urol | 2016 Jan | Kim SH | doi: 10.4111/icu.2016.57.1.63 |
| 25075101 | Minichromosome maintenance protein 7 is a risk factor for recurrence in patients with Dukes C colorectal cancer. | Anticancer Res | 2014 Aug | Ishibashi Y | - |
| 24647462 | MCM7 serves as a prognostic marker in diffuse-type gastric adenocarcinoma and siRNA-mediated knockdown suppresses its oncogenic function. | Oncol Rep | 2014 May | Kang W | doi: 10.3892/or.2014.3094 |
| 16247466 | MCM7 amplification and overexpression are associated with prostate cancer progression. | Oncogene | 2006 Feb 16 | Ren B | - |
| 27797825 | MCM7 and its hosted miR-25, 93 and 106b cluster elicit YAP/TAZ oncogenic activity in lung cancer. | Carcinogenesis | 2017 Jan | Lo Sardo F | doi: 10.1093/carcin/bgw110 |
| 28059478 | Amplified 7q21-22 gene MCM7 and its intronic miR-25 suppress COL1A2 associated genes to sustain intestinal gastric cancer features. | Mol Carcinog | 2017 Jun | Tamilzhalagan S | doi: 10.1002/mc.22614 |
| 28182015 | MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma. | Cell Death Dis | 2017 Feb 9 | Qu K | doi: 10.1038/cddis.2016.352. |
| 28628830 | Breviscapine (BVP) inhibits prostate cancer progression through damaging DNA by minichromosome maintenance protein-7 (MCM-7) modulation. | Biomed Pharmacother | 2017 Sep | Guan YB | doi: 10.1016/j.biopha.2017.06.024 |
